Compare MasterCard Inc (MA) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasterCard Inc vs Nuwellis Inc — how do they compare? MasterCard Inc trades at $542.91 (market cap $483.71B), while Nuwellis Inc trades at $2.85 (market cap $1.09M). The key difference: MasterCard Inc is far larger — about 443770.6× Nuwellis Inc's market cap, and MasterCard Inc pays a 0.64% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| MA | NUWE | |
|---|---|---|
Market Cap | $483.71B | $1.09M |
Volume | 4,635,698 | — |
Sector | Consumer Cyclical | Technology |
52-Week High | $598.96 | $527.46 |
52-Week Low | $471.55 | $2.80 |
Enterprise Value | $494.45B | -$722.58K |
Dividend Yield | 0.64% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $545.00, up 0.26% today, with strong technical support at $540 and resistance at $547. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $4.60 exceeding expectations of $4.41. Revenue grew to $32.79B in 2025, and net income margin remains high at 45.88%. Analysts maintain a bullish consensus with a $634.27 price target, citing momentum in digital payments and AI integration.
Outlook remains positive given consistent earnings outperformance and strategic initiatives in AI and financial inclusion. Key risks include competitive disruption from stablecoins and elevated valuation multiples. Institutional ownership trends show continued accumulation, supporting the bullish sentiment. The stock presents a growth opportunity but requires monitoring of payment industry evolution and valuation sustainability.
NUWE trades at $3.00, up 5.26% today, following a 35:1 reverse stock split effective June 26, 2026. The company shows a low P/E of 0.06 and P/S of 0.01, but fundamentals are weak with a -217.22% net income margin and negative ROE. Recent news highlights patent awards and pediatric market expansion, yet cash flow remains negative. Analyst coverage is limited with a split buy/hold consensus.
Outlook is speculative; growth depends on successful commercialization of Aquadex therapy and cost management. Key risks include persistent losses, high cash burn, and competitive pressures. Investors should weigh low valuation against execution risks in the medical technology sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
